WHO ICTRP trial
Examination of liver function improvement effect by administering a…
JPRN-UMIN000016198 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000016198 |
|---|---|
| Public title | Examination of liver function improvement effect by administering a Ipragliflozin. |
| Scientific title | Examination of liver function improvement effect by administering a Ipragliflozin. - Examination of liver function improvement effect by administering a Ipragliflozin. |
| Primary sponsor | Nagasaki University Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Diabetic |
| Interventions | After registration, patients are administered Ipragliflozin. (trade name: Sugura) If you do not achieve the blood glucose effect goal, patients can be used in combination with other drugs |
| Registration date | Jan 2, 2015 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: